QUADAS-3 Explanation and Elaboration: Guidance for Quality Assessment of Diagnostic Test Accuracy Studies
Annals of Internal Medicine · 2026-04 · 179 (4)
DOI: 10.7326/annals-25-04943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Internal Medicine, 2026-04. Verfasst von Clare F Davenport und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Health Sciences, University of Birmingham, and National Institute for Health and Care Research (NIHR) Birmingham Biomedical Res…. Hauptthemen laut MEDLINE: Diagnostic Tests, Routine, Review Literature as Topic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Assessing risk of bias and applicability is essential in diagnostic test accuracy reviews to produce reliable and relevant evidence that can guide clinical and policy decisions. To support this process, the authors have developed QUADAS-3, the latest version of the QUADAS tool, which is designed to assess the methodological strength and relevance of diagnostic test accuracy studies included in systematic reviews. This article explains how to use the QUADAS-3 tool. The article guides the reviewer through the initial stages of defining the questions and conceptualizing the ideal test accuracy trial, how the domains and signaling questions should be interpreted and assessed, and how judgments of risk of bias and concerns regarding applicability should be made. Authors of systematic reviews of diagnostic test accuracy studies should use this article as a guide for applying the QUADAS-3 tool.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Applied Health Sciences, University of Birmingham, and National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, United Kingdom (C.F.D., Y.T., J.J.D.).
- Departmental Faculty of Medicine, UniCamillus - Saint Camillus International University of Health Science, Rome, Italy (A.W.S.R.).
- UCL Centre for Medical Imaging, University College London, London, United Kingdom (S.M., J.H.).
- Bristol Technology Assessment Group, Bristol Medical School, University of Bristol, Bristol, United Kingdom (E.T., M.E.W., P.F.W.).
- Department of Epidemiology and Data Science, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands (B.Y., P.M.M.B., M.M.G.L.).
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands (J.B.R.).
ORCID-Profile: Clare F Davenport, Anne W S Rutjes, Sue Mallett, Eve Tomlinson, Bada Yang, Jude Holmes, Marie E Westwood, Yemisi Takwoingi, Christopher Hyde, Patrick M M Bossuyt, Mariska M G Leeflang, Penny F Whiting
Zitieren
APA
Davenport, C. F., Rutjes, A. W. S., Mallett, S., Tomlinson, E., Yang, B., Holmes, J., Westwood, M. E., Takwoingi, Y., Reitsma, J. B., Hyde, C., Bossuyt, P. M. M., Deeks, J. J., Leeflang, M. M. G., & Whiting, P. F. (2026). QUADAS-3 Explanation and Elaboration: Guidance for Quality Assessment of Diagnostic Test Accuracy Studies. Annals of Internal Medicine, 179(4). https://doi.org/10.7326/annals-25-04943
Vancouver
Davenport CF, Rutjes AWS, Mallett S, Tomlinson E, Yang B, Holmes J, et al. QUADAS-3 Explanation and Elaboration: Guidance for Quality Assessment of Diagnostic Test Accuracy Studies. Annals of Internal Medicine. 2026;179(4). doi:10.7326/annals-25-04943
BibTeX
@article{Davenport2026,
author = {Davenport, Clare F and Rutjes, Anne W S and Mallett, Sue and Tomlinson, Eve and Yang, Bada and Holmes, Jude and Westwood, Marie E and Takwoingi, Yemisi and Reitsma, Johannes B and Hyde, Christopher and Bossuyt, Patrick M M and Deeks, Jonathan J and Leeflang, Mariska M G and Whiting, Penny F},
title = {QUADAS-3 Explanation and Elaboration: Guidance for Quality Assessment of Diagnostic Test Accuracy Studies},
journal = {Annals of Internal Medicine},
year = {2026},
volume = {179},
number = {4},
doi = {10.7326/annals-25-04943}
}
EUVIMED